Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $ALTH ALLOS THERAPEUTICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Baker Brothers Life Sciences Capital (GP), LLC in ALLOS THERAPEUTICS INC

Trading Symbol: ALTH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 5,771,961 shares
Latest Transaction: Feb 06 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in ALLOS THERAPEUTICS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.26	670	5,532	5,771,961	5.8 M to 5.8 M (-0.01 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.17	751,534	6,142,889	5,772,631	6.5 M to 5.8 M (-11.52 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.11	142,827	1,157,713	6,524,165	6.7 M to 6.5 M (-2.14 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.17	36,286	296,504	6,666,992	6.7 M to 6.7 M (-0.54 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.16	193,252	1,577,574	6,703,278	6.9 M to 6.7 M (-2.80 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.46	733,340	6,203,616	6,896,530	7.6 M to 6.9 M (-9.61 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.47	78,447	664,399	7,629,870	7.7 M to 7.6 M (-1.02 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	9.03	8,160	73,703	7,708,317	7.7 M to 7.7 M (-0.11 %)
Feb 06 2009	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	8.01	286,299	2,292,196	7,716,477	8 M to 7.7 M (-3.58 %)
May 27 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	5.64	1,146,462	6,466,046	8,002,776	6.9 M to 8 M (+16.72 %)
Feb 27 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.00	85,055	510,330	6,856,314	6.8 M to 6.9 M (+1.26 %)
Feb 21 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.20	59,539	369,142	6,771,259	6.7 M to 6.8 M (+0.89 %)
Feb 21 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	5.90	63,791	376,367	6,711,720	6.6 M to 6.7 M (+0.96 %)
Feb 21 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.50	64,825	421,324	6,647,929	6.6 M to 6.6 M (+0.98 %)
Feb 21 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.75	64,259	433,973	6,583,104	6.5 M to 6.6 M (+0.99 %)
Jan 23 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.95	19,608	136,305	6,518,845	6.5 M to 6.5 M (+0.30 %)
Jan 23 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.92	555	3,838	6,499,237	6.5 M to 6.5 M (+0.01 %)
Jan 23 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.15	4,300	30,759	6,498,682	6.5 M to 6.5 M (+0.07 %)
Jan 23 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.22	4,938	35,630	6,494,382	6.5 M to 6.5 M (+0.08 %)
Jan 17 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.50	19,334	145,005	6,489,444	6.5 M to 6.5 M (+0.30 %)
Jan 14 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.41	89,632	664,603	6,470,110	6.4 M to 6.5 M (+1.40 %)
Jan 14 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.47	37,921	283,387	6,380,478	6.3 M to 6.4 M (+0.60 %)
Jan 14 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.47	79,841	596,348	6,342,557	6.3 M to 6.3 M (+1.27 %)
Jan 09 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.96	43,023	299,449	6,262,716	6.2 M to 6.3 M (+0.69 %)
Jan 09 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	7.21	137,895	994,457	6,219,693	6.1 M to 6.2 M (+2.27 %)
Jan 09 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.85	68,947	472,287	6,081,798	6 M to 6.1 M (+1.15 %)
Jan 09 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.37	858	5,464	6,012,851	6 M to 6 M (+0.01 %)
Jan 09 2008	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.37	138	879	6,011,993	6 M to 6 M (0.00 %)
Jun 21 2007	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	5.55	61,690	342,460	6,011,855	6.1 M to 6 M (-1.02 %)
Jun 21 2007	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	5.85	122,761	717,845	6,073,545	6.2 M to 6.1 M (-1.98 %)
Jun 21 2007	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	5.64	520,439	2,934,287	6,196,306	6.7 M to 6.2 M (-7.75 %)
Jun 21 2007	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Sell	S	5.76	112,152	645,581	6,716,745	6.8 M to 6.7 M (-1.64 %)
Feb 01 2007	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	6.00	2,340,978	14,045,868	6,828,897	4.5 M to 6.8 M (+52.16 %)
Nov 30 2006	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	5.50	215,309	1,184,200	4,487,919	4.3 M to 4.5 M (+5.04 %)
Nov 20 2006	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	5.75	82,023	471,321	4,272,610	4.2 M to 4.3 M (+1.96 %)
Nov 20 2006	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	5.80	110,553	641,528	4,190,587	4.1 M to 4.2 M (+2.71 %)
Nov 20 2006	ALTH	ALLOS THERAPEUTICS ...	Baker Brothers Life Sciences C ...	10% Owner	Buy	P	5.66	328,092	1,856,016	4,080,034	3.8 M to 4.1 M (+8.74 %)

Page: 1